NAPNAP Daily News

The NAPNAP Daily news is available for Members Only. You will need to login as a Member to to view all of the news.

FDA Approves Weekly Diabetes Drug.
Reuters (12/5, Clarke) reports the Food and Drug Administration approved Novo Nordisk’s weekly-injection diabetes drug Ozempic (semaglutide), which is in a class of drugs called glucagon-like peptide-1 (GLP-1) analogs. The article reports that Novo hopes...